vimarsana.com

Page 69 - ஆல்பர்ட் ஐன்ஸ்டீன் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Small Number of Covid Patients Develop Severe Psychotic Symptoms

Small Number of Covid Patients Develop Severe Psychotic Symptoms Most had no history of mental illness and became psychotic weeks after contracting the virus. Cases are expected to remain rare but are being reported worldwide. Dr. Hisam Goueli treated several psychotic patients who had never had mental health issues before, including a woman who told him she kept visualizing her children being murdered. “It was like she was experiencing a movie,” he said.Credit.Jovelle Tamayo for The New York Times Almost immediately, Dr. Hisam Goueli could tell that the patient who came to his psychiatric hospital on Long Island this summer was unusual.

Soterix Medical Announces Expanded Clinical Trials for Alzheimer s disease and Mild Cognitive Impairment

Press release content from PR Newswire. The AP news staff was not involved in its creation. Soterix Medical Announces Expanded Clinical Trials for Alzheimer’s disease and Mild Cognitive Impairment December 24, 2020 GMT (PRNewsfoto/Soterix Medical) NEW YORK, Dec. 24, 2020 /PRNewswire/ Soterix Medical Inc. , the global leader in non-invasive stimulation and synergistic brain imaging technologies, is pleased to report expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer’s disease and Mild Cognitive Impairment. Adults over age 65 represent the fastest growing population in the US. Decline in cognitive abilities is a hallmark of advanced age and is associated with loss of independence and dementia risk. Over 50 million adults worldwide are diagnosed with Alzheimer’s disease or other dementia, which puts an enormous burden on individuals, their families and caretakers, and the healthcare system. Soterix Medical technologies are at the forefront

Rabbi Dr Edward Reichman Presents Rabbinic Responses To Historic Pandemics

By Pearl Markovitz | December 24, 2020 The seemingly hackneyed phrase “The more things change, the more they stay the same” appeared to be the overarching theme in Rabbi Dr. Edward Reichman’s recent Zoom presentation, sponsored by the Dr. Bertram z”l & Ann Newman Adult Education Program of the Young Israel of Teaneck. Throughout his lecture, Rabbi Dr. Reichman addressed the halachic issues that have been raised during the past almost 10 months as compared with discussions of these same topics as far back as the Black Death in 1347. Rabbi Dr. Reichman is highly qualified to tackle a topic as overarching as “Precedented Times: The History of Pandemics in Rabbinic Literature.” Rabbi Reichman is a professor of emergency medicine and professor in the Division of Education and Bioethics in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine of Yeshiva University. He received his B.A. from Yeshiva University and M.D. from

New study: available drugs can prevent rejection and tissue injury after transplantation

 E-Mail IMAGE: Activation of monocytes (Kupffer cells) was determined with a pulse of carbon (arrows, black grains). A: Healthy liver with limited carbon incorporation indicates most Kupffer cells are inactive. B: Liver. view more  Credit: Albert Einstein College of Medicine Philadelphia, December 21, 2020 - Controlling inflammation after transplantation of organs, cells, or tissues is critical for graft survival; however, it can be difficult. Continuing injuries due to chronic rejection can be particularly problematic. Now, a team of researchers from Albert Einstein College of Medicine report that neutralizing the cell signaling molecule, tumor necrosis factor (TNF), can prevent cascades of injurious molecules and signals after cell transplantation in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.